Cell death in amastigote forms of Leishmania amazonensis induced by parthenolide

BACKGROUND: Leishmania amazonensis infection results in diverse clinical manifestations: cutaneous, mucocutaneous or visceral leishmaniasis. The arsenal of drugs available for treating Leishmania infections is limited. Therefore, new, effective, and less toxic leishmaniasis treatments are still need...

Descripción completa

Detalles Bibliográficos
Autores principales: Tiuman, Tatiana Shioji, Ueda-Nakamura, Tânia, Alonso, Antonio, Nakamura, Celso Vataru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4067685/
https://www.ncbi.nlm.nih.gov/pubmed/24913205
http://dx.doi.org/10.1186/1471-2180-14-152

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4067685/
https://www.ncbi.nlm.nih.gov/pubmed/24913205
http://dx.doi.org/10.1186/1471-2180-14-152

Ejemplares similares